Synthon Holding
Manufacturing · Netherlands · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Microweg 22, Nijmegen, Gelderland, Nethe...Phone Number
+31 243727700Website
www.synthon.comRevenue
$273.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Synthon Holding
The company started its biopharmaceutical franchise in 2007 and is building a promising portfolio of next generation medicines. Synthon is developing rapidly into a specialty pharmaceutical company, focusing on the therapeutic areas of oncology and auto-immune diseases.Explore more
Synthon Holding Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Synthon Holding your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Synthon Holding recently announced quarterly report
Synthon Holding, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Synthon Holding has new funding data
Check out if Synthon Holding is spiking on competitors!
Product Launch: Get notified when Synthon Holding launches new products
Check if Synthon Holding has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Synthon Holding
Click to see if Synthon Holding had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Synthon Holding as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Synthon Holding is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Synthon Holding is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Synthon Holding.
Synthon Holding Tech Stack
A closer look at the technologies used by Synthon Holding
See more technologies
Most Recent Scoops
Open Position
Hiring Plans
Synthon Holding has more open roles in Operations than it has had at any time in the past 12 months with an increased focus on technologies like SAP.
Hiring Plans
Hiring Plans
Synthon Holding has more open roles in Engineering & Technical than it has had at any time in the past 6 months.
Hiring Plans
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Hiring Plans
Hiring Plans
Synthon Holding News & Media
BC Partners Nears Sale of Synthon to Goldman Asset Arm - Yahoo Finance
(Bloomberg) -- BC Partners is nearing a deal to sell Dutch generic drugmaker Synthon International Holding BV to Goldman Sachs Asset Management, according to people familiar with the matter.Most Read from BloombergHong Kong's Expat Party Hub Reshaped by Chinese InfluxHow California Sees the World, and ItselfCity Hall Is HiringAmerican Institute of Architects CEO ResignsLondon’s Tube Fares Are Set to Rise by 4.6% Next YearThe Goldman asset arm, or GSAM, has emerged as the likeliest buyerAnish Mehta appointed as Synthon CEO
Previously, he has worked at Theramex and AllerganSynthon BV Appoints Anish Mehta as Chief Executive Officer and Member of the Board of Directors
NIJMEGEN, The Netherlands--(BUSINESS WIRE)--The Supervisory Board of Synthon BV, an international, science-centered pharmaceutical company specialized in developing and manufacturing high-quality generic and hybrid medicines for patients around the world, is pleased to announce that Anish Mehta is appointed as Chief Executive Officer and member of the Board of Directors, effective immediately. “We are delighted to welcome Anish to Synthon”, said Hans Stols, Executive Chairman. “Anish’s successfBC Partners to Acquire Synthon International Holding B.V., a Global Market Leader in the Development of Complex Generics
LONDON--(BUSINESS WIRE)--Funds advised by BC Partners (“BC Partners”), a leading international private equity firm, have reached an agreement to acquire a majority stake in Synthon International Holding B.V. (“Synthon” or “the Company”), a global market leader in the development of complex Generics, from its parent company Synthon Holding B.V. (“the Parent”). BC Partners will partner with Synthon’s founder Dr. Jacques Lemmens, who will remain a shareholder in the Company. The Company will be ca
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Synthon Holding
Sign Up For FreeTo access detailed company insights
The company started its biopharmaceutical franchise in 2007 and is building a promising portfolio of next generation medicines. Synthon is developing rapidly into a specialty pharmaceutical company, focusing on the therapeutic areas of oncology and auto-immune diseases.... Read More
